The mTORC1-autophagy pathway is a target for senescent cell elimination
Olena Kucheryavenko1,2, Glyn Nelson1, Thomas von Zglinicki3
1Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, NE4 5PL, UK.
Abstract:
Cellular senescence has recently been established as a key driver of organismal ageing. The state of senescence is controlled by extensive rewiring of signalling pathways, at the heart of which lies the mammalian Target of Rapamycin Complex I (mTORC1). Here we discuss recent publications aiming to establish the mechanisms by which mTORC1 drives the senescence program. In particular, we highlight our data indicating that mTORC1 can be used as a target for senescence cell elimination in vitro. Suppression of mTORC1 is known to extend lifespan of yeast, worms, flies and some mouse models and our proof-of-concept experiments suggest that it can also act by reducing senescent cell load in vivo.
Insights
Cellular senescence drives organismal aging. Targeting the mammalian Target of Rapamycin Complex I (mTORC1) pathway may eliminate senescent cells, potentially reducing aging and extending lifespan.
Area of Science:
- Cellular and Molecular Biology
- Gerontology
- Biochemistry
Background:
- Cellular senescence is a key factor in organismal aging.
- The mammalian Target of Rapamycin Complex I (mTORC1) pathway is central to senescence.
- mTORC1 signaling controls the senescence program through extensive pathway rewiring.
Purpose of the Study:
- To elucidate the mechanisms by which mTORC1 drives cellular senescence.
- To investigate mTORC1 as a therapeutic target for eliminating senescent cells.
- To assess the potential of mTORC1 suppression in reducing senescent cell burden and extending lifespan.
Main Methods:
- Review of recent publications on mTORC1 and senescence mechanisms.
- In vitro experiments targeting mTORC1 for senescent cell elimination.
- Proof-of-concept in vivo experiments to evaluate mTORC1 suppression effects.
Main Results:
- mTORC1 plays a critical role in driving the senescence program.
- mTORC1 inhibition effectively eliminates senescent cells in vitro.
- Suppression of mTORC1 shows potential for reducing senescent cell load in vivo.
Conclusions:
- mTORC1 is a crucial regulator of cellular senescence.
- Targeting mTORC1 offers a promising strategy for senescent cell elimination.
- Further research into mTORC1 inhibition may lead to interventions for aging and age-related diseases.
Related Concept Videos
Replicative Cell Senescence
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Elimination Kinetics: First-Order and Zero-Order
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is a drug's half-life, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Elimination Reactions
Radical Formation: Elimination


